GLP-1 and Akkermansia, the Rest of the Story
It is possible to encourage one’s personal stock of the helpful bacterium by eating its favorite foods, like high-fiber vegetation and nondigestible carbs.
GLP-1 and Akkermansia, a Glowing Prospect
The mucus-loving bacterium Akkermansia muciniphila offers a glimpse of an exciting future of drug-free therapy that achieves sustainable weight loss.
GLP-1 and Akkermansia
One of the interesting challenges taken up by scientists in the past few years has been how to convince a body to make more GLP-1 on its own.
Maximizing GLP-1 Treatment Success
A new joint advisory from four major clinical organizations provides a much-needed roadmap to help patients get the most out of GLP-1 medications for obesity.
New Research on GLP-1 Receptor Agonists vs. Pediatric Obesity
GLP-1 medications show promise for weight loss in children, with added benefit of easing food-related family tensions.
Do I Have to Take a GLP-1 Medication Forever?
Must you take your GLP-1 medication forever to avoid weight gain and other adverse effects? Here’s what you need to know about them and life after them.
FDA Ends Compounding for Popular GLP-1 Drugs
Consumers who have relied on less expensive, compounded versions — often obtained through telehealth services or medical spas — will need to find other options.
A Probiotic, and a GLP-1 Non-Substitute
The longer the subject is pursued, the more it seems that debunking berberine has become a minor industry.
Are GLP-1 Receptor Agonists Safe for Children?
As the use of adolescent use of GLP-1 medications surges, research looks into their safety and natural alternatives.
Experts Continue Evaluating Benefits and Risks of GLP-1 Agonists
A new tailored approach to using GLP-1 receptor agonists for obesity management achieves nearly twice the weight loss.